Work With Us
We are building a world-class team of professionals who are motivated by the opportunity to make a significant contribution to the health and well-being of others.
PIONEERING NEW TECHNOLOGIES
NeuroVista Corporation is an early-stage medical device company pioneering new technologies that will revolutionize the management and treatment of epilepsy, a neurological condition affecting approximately 1% of the U.S. population—more than Parkinson's disease, multiple sclerosis and Lou Gehrig's disease combined.
COMPANY NEWS
NeuroVista and Partners to Explore New Ways to Predict and Control Seizures
NeuroVista Featured as a Promising New Epilepsy Therapy at 2012 Epilepsy Pipeline Update Conference
NeuroVista Announces Preliminary Algorithm Performance of Seizure Advisory System
NeuroVista Receives Approval for Expanding Australian Clinical Study
NeuroVista Completes Initial Enrollment in
Australian Clinical Study
NeuroVista Announces First-in-Man Milestone in
Australian Clinical Study
World First Trial Gives Hope to Epilepsy Sufferers, Australian Broadcasting Company, The 7:30 Report
NeuroVista Completes Convertible Debt Agreement and Second Technology License with Cyberonics
NeuroVista Raises $16.5 Million in Equity Financing
NeuroVista Corporation Receives Gold Electrode Award for “Most Promising Start-up Company”
NeuroVista Raises $33.8 Million in Series B Financing, Company Changes Name from BioNeuronics